全文获取类型
收费全文 | 33152篇 |
免费 | 2068篇 |
国内免费 | 265篇 |
专业分类
耳鼻咽喉 | 445篇 |
儿科学 | 599篇 |
妇产科学 | 491篇 |
基础医学 | 4074篇 |
口腔科学 | 1553篇 |
临床医学 | 2724篇 |
内科学 | 8947篇 |
皮肤病学 | 392篇 |
神经病学 | 3348篇 |
特种医学 | 1305篇 |
外科学 | 5282篇 |
综合类 | 93篇 |
一般理论 | 6篇 |
预防医学 | 1396篇 |
眼科学 | 546篇 |
药学 | 1727篇 |
中国医学 | 72篇 |
肿瘤学 | 2485篇 |
出版年
2024年 | 32篇 |
2023年 | 361篇 |
2022年 | 670篇 |
2021年 | 1256篇 |
2020年 | 745篇 |
2019年 | 1022篇 |
2018年 | 1205篇 |
2017年 | 956篇 |
2016年 | 1068篇 |
2015年 | 1130篇 |
2014年 | 1460篇 |
2013年 | 1778篇 |
2012年 | 2776篇 |
2011年 | 2672篇 |
2010年 | 1499篇 |
2009年 | 1363篇 |
2008年 | 2145篇 |
2007年 | 2256篇 |
2006年 | 2029篇 |
2005年 | 1842篇 |
2004年 | 1643篇 |
2003年 | 1496篇 |
2002年 | 1297篇 |
2001年 | 262篇 |
2000年 | 235篇 |
1999年 | 241篇 |
1998年 | 240篇 |
1997年 | 201篇 |
1996年 | 153篇 |
1995年 | 140篇 |
1994年 | 126篇 |
1993年 | 106篇 |
1992年 | 117篇 |
1991年 | 93篇 |
1990年 | 80篇 |
1989年 | 54篇 |
1988年 | 85篇 |
1987年 | 61篇 |
1986年 | 44篇 |
1985年 | 63篇 |
1984年 | 52篇 |
1983年 | 43篇 |
1982年 | 47篇 |
1981年 | 29篇 |
1980年 | 24篇 |
1979年 | 41篇 |
1978年 | 30篇 |
1977年 | 22篇 |
1973年 | 31篇 |
1972年 | 26篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Novo G Rizzo M La Carruba S Caruso M Amoroso GR Balistreri CR Coppola G Evola G Caruso C Assennato P Novo S Mancuso D 《Angiology》2012,63(2):127-130
We assessed whether macrophage colony-stimulating factor (M-CSF) levels are associated with left ventricular systolic dysfunction (LVSD) in patients with acute myocardial infarction (AMI). We studied 56 patients with AMI (mean age: 67 ± 12 years) and identified those with clinical (Killip class >II) or echocardiographic signs (ejection fraction ≤45%) of LVSD. We evaluated the established cardiovascular risk factors and measured several cardiovascular biomarkers, including M-CSF. Serum M-CSF concentrations (pg/mL) were significantly increased in patients with both clinical and echocardiographic signs of LVSD (460 ± 265 vs 290 ± 210, P = .0103 and 493 ± 299 vs 287 ± 174, P = .0028, respectively). We found a significant inverse association between M-CSF and ejection fraction (r = -.351, P = .0079). Logistic regression analysis revealed that, among all evaluated clinical and biochemical parameters, the stronger predictor of LVSD was M-CSF (odds ratios 2.1, 95% confidence interval 1.1-2.9, P = .0168). This is the first study reporting plasma M-CSF levels as independent determinants of low LV ejection fraction and clinical LV dysfunction in patients with AMI. 相似文献
993.
Manetti M Allanore Y Saad M Fatini C Cohignac V Guiducci S Romano E Airó P Caramaschi P Tinazzi I Riccieri V Della Rossa A Abbate R Caporali R Cuomo G Valesini G Dieudé P Hachulla E Cracowski JL Tiev K Letenneur L Amouyel P Lambert JC Chiocchia G Martinez M Ibba-Manneschi L Matucci-Cerinic M 《Annals of the rheumatic diseases》2012,71(6):1034-1041
994.
Toplak N Frenkel J Ozen S Lachmann HJ Woo P Koné-Paut I De Benedetti F Neven B Hofer M Dolezalova P Kümmerle-Deschner J Touitou I Hentgen V Simon A Girschick H Rose C Wouters C Vesely R Arostegui J Stojanov S Ozgodan H Martini A Ruperto N Gattorno M;Paediatric Rheumatology International Trials Organisation 《Annals of the rheumatic diseases》2012,71(7):1177-1182
995.
996.
997.
Muñoz F Del Río N Sóñora C Tiscornia I Marco A Hernández A 《European journal of oral sciences》2012,120(2):104-112
Enamel defects in the permanent teeth of patients with coeliac disease (CD) are often reported as an atypical manifestation, sometimes being suggestive of an undiagnosed atypical disease. We proposed to explore the pathogenesis of these oral defects, which are poorly studied. Sequence analyses of proteins from gluten (gliadins) and of proline-rich enamel proteins (amelogenin and ameloblastin) suggested the presence of common antigenic motifs. Therefore, we analyzed, by ELISA and western blotting, the reactivity of sera from patients with CD against gliadin and enamel-derived peptides. Correlation analyses between the levels of specific antibodies against gliadin and enamel derived peptides and inhibition experiments confirmed the presence of cross-reactive antibodies. Immunoblot analysis revealed that the most prominent component in enamel matrix derivative (of approximately 18.6 kDa), identified by an amelogenin-specific antibody, is recognized by sera from patients with CD; in addition, several fractions of pure gliadin were recognized by amelogenin-specific antibody. In agreement, sera from mice immunized with enamel matrix-derived proteins generated antibodies that recognized a peptide (of approximately 21.2 kDa) derived from gliadin. In conclusion, antibodies against gliadin generated in patients with CD can react in vitro with a major enamel protein. The involvement of anti-gliadin serum in the pathogenesis of enamel defects in children with untreated CD can be hypothesized on the basis of these novel results. 相似文献
998.
999.
Andreas Kolk Jörg Handschel Wolf Drescher Daniel Rothamel Frank Kloss Marco Blessmann Max Heiland Klaus-Dietrich Wolff Ralf Smeets 《Journal of cranio-maxillo-facial surgery》2012,40(8):706-718
An autologous bone graft is still the ideal material for the repair of craniofacial defects, but its availability is limited and harvesting can be associated with complications. Bone replacement materials as an alternative have a long history of success. With increasing technological advances the spectrum of grafting materials has broadened to allografts, xenografts, and synthetic materials, providing material specific advantages. A large number of bone-graft substitutes are available including allograft bone preparations such as demineralized bone matrix and calcium-based materials. More and more replacement materials consist of one or more components: an osteoconductive matrix, which supports the ingrowth of new bone; and osteoinductive proteins, which sustain mitogenesis of undifferentiated cells; and osteogenic cells (osteoblasts or osteoblast precursors), which are capable of forming bone in the proper environment. All substitutes can either replace autologous bone or expand an existing amount of autologous bone graft.Because an understanding of the properties of each material enables individual treatment concepts this review presents an overview of the principles of bone replacement, the types of graft materials available, and considers future perspectives. Bone substitutes are undergoing a change from a simple replacement material to an individually created composite biomaterial with osteoinductive properties to enable enhanced defect bridging. 相似文献
1000.